Effects of Anxiety and Depression on Neuroendocrine Immune Network in Patients with Ulcerative Colitis

doi:10.12114/j.issn.1007-9572.2019.00.318

Abstract

Abstract: Background　Ulcerative colitis （UC） is a common disease in the Department of Gastroenterology.At present，the etiology and pathogenesis of UC are not very clear.In recent years，many studies have shown that psycho-psychological factors are involved in the occurrence of UC.Therefore，it is worth exploring the mechanism of psycho-psychological factors in the onset of UC.Objective　To investigate the effect of anxiety and depression on neuroendocrine immune network in patients with UC.Methods　A total of 198 outpatients and inpatients with UC in the Department of Gastroenterology of the Second People's Hospital of Lianyungang，Affiliated Hospital of Bengbu Medical College and the First Affiliated Hospital of Bengbu Medical College from January 2013 to November 2018 were divided into remission stage group （group A，57 cases） and active stage group （group B，141 cases）．Group B was divided into mild active stage （subgroup B1，83 cases） and moderate-severe active stage （subgroup B2，58 cases） according to the severity of the disease.Sixty-two patients with anxiety and/or depression among 121 patients with mild-moderate active stage were divided into control group（n=31） and intervention group（n=31） by random number table method.The control group was treated with mesalazine enteric-coated tablets and the intervention group was treated with psychological intervention+Flupentixol and Melitracen Tablets+mesalazine enteric-coated tablets.Thirty-two healthy persons were selected as the health examination group in the same period.The Hamilton Anxiety Scale （HAMA） and Hamilton Depression Scale （HAMD） were used to determine the anxiety and depression of the subjects after 4 weeks of treatment.The levels of serotonin（5-HT），interleukin（IL）-6，IL-8 and IL-2 were measured by enzyme-linked immunosorbent assay （ELISA）．Results　The scores of HAMA，HAMD and levels of 5-HT，IL-6 and IL-8 in healthy examination group，group A and subgroup B1 were lower than those in case group，group B and subgroup B2，and the levels of IL-2 were higher than those in case group，group B and subgroup B2，respectively （P<0.01）．Pearson correlation analysis showed that HAMA and HAMD score were positively correlated with 5-HT，IL-6，IL-8 and negatively correlated with IL-2 （P<0.001）．After 4 weeks of treatment，HAMA and HAMD scores，5-HT，IL-6 and IL-8 levels in the intervention group were lower than those in the control group，and IL-2 level was higher than that in the control group （P<0.05）；HAMA and HAMD scores，5-HT，IL-6 and IL-8 levels in the control group and the intervention group after treatment were lower than those before treatment，and IL-2 levels were higher than those before treatment （P<0.05）．Conclusion　Anxiety and depression are closely correlated to the pathogenesis of UC，which may participate in the pathogenesis of UC by affecting related indicators of neuroendocrine immune network.

Key words: Colitis, ulcerative；Anxiety；Depression；Neuroendocrine cells；Cytokines

摘要： 背景　溃疡性结肠炎（UC）是消化内科常见病，目前，该病病因和发病机制尚不十分明确，近年来，多项研究显示，精神心理因素可能也参与了UC的发病，但精神心理因素到底通过何种机制参与UC的发病，是值得探讨的问题。目的　探讨焦虑、抑郁心理对UC患者神经内分泌免疫的影响。方法　选取2013年1月—2018年11月在蚌埠医学院附属连云港市第二人民医院和蚌埠医学院第一附属医院消化内科就诊的门诊及住院UC患者198例为病例组，根据病情分期将其分为缓解期（A组）57例和活动期（B组）141例。B组根据病情严重程度分为轻度活动期（B1亚组）83例和中-重度活动期（B2亚组）58例。121例轻-中度活动期患者中合并焦虑和/或抑郁者62例，采用随机数字表法将其分为对照组31例和干预组31例，对照组予“美沙拉嗪肠溶片”治疗，干预组予“心理干预+氟哌噻吨美利曲辛片+美沙拉嗪肠溶片”治疗。另选取同期在两院体检健康者32例作为健康体检组。于纳入研究和治疗4周后采用汉密尔顿焦虑量表（HAMA）和汉密尔顿抑郁量表（HAMD）测定研究对象焦虑、抑郁情况，并采用酶联免疫吸附试验（ELISA）测定5羟色胺（5-HT）、白介素（IL）-6、IL-8、IL-2水平。结果　健康体检组、A组、B1亚组HAMA、HAMD评分及5-HT、IL-6、IL-8水平均分别低于病例组、B组、B2亚组，IL-2水平均分别高于病例组、B组、B2亚组（P<0.01）。Pearson相关分析结果显示，病例组HAMA评分、HAMD评分均与5-HT、IL-6、IL-8呈正相关，与IL-2呈负相关（P<0.001）。治疗4周后，干预组HAMA、HAMD评分及5-HT、IL-6、IL-8水平均低于对照组，IL-2水平高于对照组（P<0.05）；对照组和干预组治疗后HAMA、HAMD评分及5-HT、IL-6、IL-8水平均低于治疗前，IL-2水平均高于治疗前（P<0.05）。结论　焦虑、抑郁心理与UC发病密切相关，其可能通过影响神经内分泌免疫相关指标而参与UC的发病。

关键词: 结肠炎, 溃疡性；焦虑；抑郁；神经内分泌细胞；细胞因子类

ZHAO Changdong,ZHAO Hongyan,KE Xiquan, et al. Effects of Anxiety and Depression on Neuroendocrine Immune Network in Patients with Ulcerative Colitis　[J]. Chinese General Practice, 2020, 23(2): 234-239. DOI: 10.12114/j.issn.1007-9572.2019.00.318.
赵昌东,赵红艳,柯希权等. 焦虑与抑郁心理对溃疡性结肠炎患者神经内分泌免疫的影响研究[J]. 中国全科医学, 2020, 23(2): 234-239. DOI: 10.12114/j.issn.1007-9572.2019.00.318.

References

［1］葛均波，徐永健，王辰.内科学［M］．9版.北京：人民卫生出版社，2018：373.
GE J B，XU Y J，WANG C.Internal medicine［M］．9th ed.Beijing：People's Health Publishing House，2018：373.
［2］REGUEIRO M，GREER J B，SZIGETHY E.Etiology and treatment of pain and psychosocial issues in patients with inflammatory bowel diseases［J］．Gastroenterology，2017，152（2）：430-439.e4．DOI：10.1053/j.gastro.2016.10.036.
［3］SELINGER C P，CARBERY I，WARREN V，et al．The relationship between different information sources and disease-related patient knowledge and anxiety in patients with inflammatory bowel disease［J］．Aliment Pharmacol Ther，2017，45（1）：63-74．DOI：10.1111/apt.13831.
［4］NEUENDORF R，HARDING A，STELLO N，et al．Depression and anxiety in patients with inflammatory bowel disease：a systematic review［J］．J Psychosom Res，2016，87：70-80．DOI：10.1016/j.jpsychores.2016.06.001.
［5］NOWAKOWSKI J，CHROBAK A A，DUDEK D.Psychiatric illnesses in inflammatory bowel diseases - psychiatric comorbidity and biological underpinnings［J］．Psychiatr Pol，2016，50（6）：1157-1166．DOI：10.12740/PP/62382.
［6］BRZOZOWSKI B，MAZUR-BIALY A，PAJDO R，et al．Mechanisms by which stress affects the experimental and clinical inflammatory bowel disease （IBD）：role of brain-gut axis［J］．Curr Neuropharmacol，2016，14（8）：892-900.
［7］SGAMBATO D，MIRANDA A，RANALDO R，et al．The role of stress in inflammatory bowel diseases［J］．Curr Pharm Des，2017，23（27）：3997-4002．DOI：10.2174/1381612823666170228123357.
［8］中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见（2018年?北京）［J］．中国实用内科杂志［J］．2018，38（9）：796-813.
Group of Inflammatory Bowel Disease，Gastroenterology Branch，Chinese Medical Association.Consensus on diagnosis and treatment of inflammatory bowel disease（Beijing，2018）［J］．Chinese Journal of Practical Internal Medicine，2018，38（9）：796-813.
［9］张作记.行为医学量表手册［M］．北京：中华医学电子音像出版社，2005：225-227.
ZHANG Z J.Behavioral medicine scale handbook［M］．Beijing：Chinese Medical Audio-visual Publishing House，2005：225-227.
［10］TRIANTAFILLIDIS J K，MERIKAS E，GIKAS A.Psychological factors and stress in inflammatory bowel disease［J］．Expert Rev Gastroenterol Hepatol，2013，7（3）：225-238．DOI：10.1586/egh.13.4.
［11］MORYS J M，KACZóWKA A，JEZEWSKA M.Assessment of selected psychological factors in patients with inflammatory bowel disease［J］．Prz Gastroenterol，2016，11（1）：47-53．DOI：10.5114/pg.2015.52560.
［12］TABATABAEIAN M，AFSHAR H，ROOHAFZA H R，et al．Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life［J］．J Res Med Sci，2015，20（6）：577-584．DOI：10.4103/1735-1995.165962.
［13］宋金远，杨晨玉，王子旭，等．5-羟色胺影响肠黏膜上皮细胞屏障的研究进展［J］．中国畜牧兽医，2014，41（9）：154-157.
SONG J Y，YANG C Y，WANG Z X，et al．Research progress on effect of 5-hydroxytryptamine on the barrier of intestinal mucosal epithelial cell［J］．China Animal Husbandry & Veterinary Medicine，2014，41（9）：154-157.
［14］YANO J M，YU K，DONALDSON G P，et al．Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis［J］．Cell，2015，161（2）：264-276．DOI：10.1016/j.cell.2015.02.047.
［15］SIKANDER A，SINHA S K，PRASAD K K，et al．Association of serotonin transporter promoter polymorphism （5-HTTLPR） with microscopic colitis and ulcerative colitis［J］．Dig Dis Sci，2015，60（4）：887-894．DOI：10.1007/s10620-014-3482-y.
［16］YU F Y，HUANG S G，ZHANG H Y，et al．Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis［J］．World J Gastroenterol，2016，22（12）：3451-3459．DOI：10.3748/wjg.v22.i12.3451.
［17］SHAJIB M S，KHAN W I.The role of serotonin and its receptors in activation of immune responses and inflammation［J］．Acta Physiol （Oxf），2015，213（3）：561-574．DOI：10.1111/apha.12430.
［18］ZHANG F，YAO S M，ZHANG M X，et al．Roles of circulating soluble interleukin （IL）-6 receptor and IL-6 receptor expression on CD4+ T cells in patients with chronic hepatitis B［J］．Int J Infect Dis，2011，15（4）：e267-271．DOI：10.1016/j.ijid.2010.12.008.
［19］GUPTA R A，MOTIWALA M N，MAHAJAN U N，et al．Protective effect of Sesbania grandiflora on acetic acid induced ulcerative colitis in mice by inhibition of TNF-α and IL-6［J］．J Ethnopharmacol，2018，219：222-232．DOI：10.1016/j.jep.2018.02.043.
［20］NISHIDA Y，HOSOMI S，WATANABE K，et al．Serum interleukin-6 level is associated with response to infliximab in ulcerative colitis［J］．Scand J Gastroenterol，2018，53（5）：579-585．DOI：10.1080/00365521.2017.1403647.
［21］ZHANG H F，CHEN W C.Interleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitis［J］．Exp Ther Med，2017，14（3）：2271-2276．DOI：10.3892/etm.2017.4778.
［22］VELIKOVA T，KYURKCHIEV D，SPASSOVA Z，et al．Alterations in cytokine gene expression profile in colon mucosa of inflammatory bowel disease patients on different therapeutic regimens［J］．Cytokine，2017，92：12-19．DOI：10.1016/j.cyto.2017.01.008.
［23］WALANA W，YE Y，LI M，et al．IL-8 antagonist，CXCL8（3-72）K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis［J］．Biomed Pharmacother，2018，103：253-261．DOI：10.1016/j.biopha.2018.04.008.
［24］KALLIOM?KI M，RAJALA S，ELAMO H，et al．Increased expression of CXCL16，a bacterial scavenger receptor，in the colon of children with ulcerative colitis［J］．J Crohns Colitis，2014，8（10）：1222-1226．DOI：10.1016/j.crohns.2014.02.016.
［25］EBRAHIMPOUR S，SHAHBAZI M，KHALILI A，et al．Elevated levels of IL-2 and IL-21 produced by CD4+ T cells in inflammatory bowel disease［J］．J Biol Regul Homeost Agents，2017，31（2）：279-287.
［26］SAVIC MLAKAR A，HOJSAK I，JERGOVIC M，et al．Comparison of cytokine and efflux transporter expression in pediatric versus adult-onset ulcerative colitis［J］．J Pediatr Gastroenterol Nutr，2017，64（6）：943-948.
［27］黎莉，杨卫文，谭松，等．溃疡性结肠炎患者外周血及结肠黏膜TNF-α、IL-6和IL-2变化的临床意义［J］．中国现代医学杂志，2016，26（14）：42-47.
LI L，YANG W W，TAN S，et al．Changes of TNF-α，IL-6 and IL-2 in peripheral blood and colonic mucosa of ulcerative colitis patients［J］．China Journal of Modern Medicine，2016，26（14）：42-47.
［28］VAN ASSCHE G，DALLE I，NOMAN M，et al．A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis ［J］．Am J Gastroenterol，2003，98（2）：369-376．DOI：10.1111/j.1572-0241.2003.07239.x.

[1]	CHEN Xiaofen, CHEN Yuhan, MA Juan. Recent Strides in Novel Treatments for Inflammatory Bowel Disease [J]. Chinese General Practice, 2023, 26(27): 3349-3354.
[2]	Zhenzhen JUE, Juan SONG, Xiangmin ZHANG, Han ZHANG, Huimin DONG, Wendong LI, Falin XU. Risk Factors for Adverse Neurodevelopment Outcomes in Neonates with Necrotizing Enterocolitis [J]. Chinese General Practice, 2022, 25(18): 2275-2279.
[3]	Xiaofei MA, Jiali HU, Manman CUI, Wei GE, Suqin YANG, Chenghua DING, Leichang ZHANG. Medicinal Flavor of Fecal Microbiota and Efficacies of Its Transplantation in Mice with Different Types of Ulcerative Colitis [J]. Chinese General Practice, 2022, 25(15): 1875-1882.
[4]	Zhanpeng LIU, Xiaozhong YANG, Mengxue CHEN, Menghui ZHANG, Honggang WANG. Clinical Value of Inflammatory Bowel Disease Symptom Inventory in Evaluating the Activity of Inflammatory Bowel Disease [J]. Chinese General Practice, 2022, 25(14): 1713-1718.
[5]	LENG Xinying, ZOU Huachun, FU Leiwen, KE Wujian. Summary of the Essentials for the Diagnosis and Treatment of Sexually Transmitted Proctitis，Proctocolitis and Enteritis from CDC's Sexually Transmitted Infections Treatment Guidelines，2021 [J]. Chinese General Practice, 2022, 25(06): 651-655.
[6]	MO Dayu, LIU Yingchao, WANG Feida, NI Siyi, SHEN Yan. Efficacy and Safety of Wuling Capsule Combined with Fupentixol and Melitracen Tablets in Active Ulcerative Colitis Patients Accompanied with Anxiety and Depression [J]. Chinese General Practice, 2022, 25(03): 285-292.
[7]	PENG Bin, WEN Yi, ZHANG Shijing, LIN Wenjia, LI Huibiao, CAI Jiazhong, LIU Shiying, LUO Jianfeng, LUO Yongxin, ZHENG Xiaomei, PAN Simin, CHEN Xinlin, HOU Jiangtao. N-of-1 Trial of Jianpiqingrehuashi Granular Decoction with Mesalamine in the Treatment of Ulcerative Colitis in Remission with Spleen Deficiency-induced Damp-heat Syndrome [J]. Chinese General Practice, 2022, 25(03): 293-297.
[8]	WENG Jianfeng, XU Jia, LIU Peng, GE Wei, CHEN Jiaohua, PENG Yingying, HU Jiali, CUI Manman, ZHANG Leichang. Immunological Mechanism of Faecal Bacterial Transplantation in the Intervention of Ulcerative Colitis [J]. Chinese General Practice, 2022, 25(03): 298-304.
[9]	PENG Ying，XU Lihong. Application of Histopathological Disease Activity Indices in Ulcerative Colitis　 [J]. Chinese General Practice, 2021, 24(21): 2634-2639.
[10]	WU Rong，WANG Yingde，MAO Jingwei. Opportunistic Viral Infections in Patients with Inflammatory Bowel Disease：Clinical Features and Management Strategies　 [J]. Chinese General Practice, 2021, 24(15): 1853-1860.
[11]	ZHU Xiaobo，MA Faxin，FENG Lin，ZHENG Yue，SHA Weihong，CHEN Hao. Conditioned Medium Derived from Bone Marrow Mesenchymal Stem Cells with Inflammatory Pre-activation Regulates Inflammatory Response to Necrotizing Enterocolitis　 [J]. Chinese General Practice, 2019, 22(36): 4453-4459.
[12]	LI Wei，HU Fenglin，LI Jiyan 3. Precautions for the Treatment of Ulcerative Colitis with Traditional Chinese Medicine Retention Enema　 [J]. Chinese General Practice, 2019, 22(30): 3714-3716.
[13]	LI Wenkun，LIU Kuiliang，WU Jing. Analysis of Clinical Features of 22 Cases of Cryptogenic Multifocal Ulcerous Stenosing Enteritis　 [J]. Chinese General Practice, 2018, 21(36): 4527-4530.
[14]	HE Shan，LI Li，YANG Jing-hui. Fecal Calprotectin in Response to Transfusion of Red Blood Cell Suspension in Very Low Birth Weight Infants [J]. Chinese General Practice, 2018, 21(26): 3236-3239.